DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth.
Precision medicine is coming to PitNETs.
DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth.
Precision medicine is coming to PitNETs.
The EYRC is currently recruiting 1 new board member!
Please send your CV and a letter of intent to eyrc.enea@endoscience.de
(CC: giampaolo.trivellin@gmail.com)
Application deadline: January 31st, 2026
The EYRC is currently recruiting 1 new board member!
Please send your CV and a letter of intent to eyrc.enea@endoscience.de
(CC: giampaolo.trivellin@gmail.com)
Application deadline: January 31st, 2026
๐ More on LinkedIn: @enea-young-researcher-committee
๐ More on LinkedIn: @enea-young-researcher-committee
๐ More on LinkedIn: @enea-young-researcher-committee
๐ More on LinkedIn: @enea-young-researcher-committee
A small gland with a big impact โ the pituitary controls growth, stress, reproduction & more.
Early recognition of pituitary disorders can save lives.
A small gland with a big impact โ the pituitary controls growth, stress, reproduction & more.
Early recognition of pituitary disorders can save lives.
The EYRC is kicking off a new edition of Neuroendocrinology Watch โ highlighting the latest insights in our field!
๐Brutvan et al., Endocrine Connections (2025)
๐ doi.org/10.1530/EC-2...
More on LinkedIn: @enea-young-researcher-committee
The EYRC is kicking off a new edition of Neuroendocrinology Watch โ highlighting the latest insights in our field!
๐Brutvan et al., Endocrine Connections (2025)
๐ doi.org/10.1530/EC-2...
More on LinkedIn: @enea-young-researcher-committee
He shares challenges, opportunities & advice for young endocrinologists.
๐ Full video & details on LinkedIn: @enea-young-researcher-committee
๐ 3โ5 Dec | Marseille
Theme: Changing the Paradigms โ Translational Approach in Pituitary Tumors
๐ Deadline: 15 Sept 2025
โ๏ธ Max 300 words | <41y = YIA eligible
๐ฉ eneacongress@aoscongres.com
๐ lnkd.in/e4yUiGZ9
๐ 3โ5 Dec | Marseille
Theme: Changing the Paradigms โ Translational Approach in Pituitary Tumors
๐ Deadline: 15 Sept 2025
โ๏ธ Max 300 words | <41y = YIA eligible
๐ฉ eneacongress@aoscongres.com
๐ lnkd.in/e4yUiGZ9
Call for Abstracts โ ENEA Workshop 2025 | Marseille, France ๐ซ๐ท
๐ Workshop Dates: 3โ5 December 2025
๐ง Theme: Changing the Paradigms Over 20 Years โ A Translational Approach in Pituitary Tumors
๐ More on LinkedIn: @enea-young-researcher-committee
Call for Abstracts โ ENEA Workshop 2025 | Marseille, France ๐ซ๐ท
๐ Workshop Dates: 3โ5 December 2025
๐ง Theme: Changing the Paradigms Over 20 Years โ A Translational Approach in Pituitary Tumors
๐ More on LinkedIn: @enea-young-researcher-committee
Workshop Dates: 3โ5 December 2025
More on LinkedIn: @enea-young-researcher-committee
Workshop Dates: 3โ5 December 2025
More on LinkedIn: @enea-young-researcher-committee
๐ Workshop Dates: 3โ5 December 2025
๐ง Theme: Changing the Paradigms Over 20 Years โ A Translational Approach in Pituitary Tumors
๐ More on LinkedIn: @enea-young-researcher-committee
๐ Workshop Dates: 3โ5 December 2025
๐ง Theme: Changing the Paradigms Over 20 Years โ A Translational Approach in Pituitary Tumors
๐ More on LinkedIn: @enea-young-researcher-committee
๐ More on LinkedIn: @enea-young-researcher-committee
๐ More on LinkedIn: @enea-young-researcher-committee
We spotlight a study that investigates how acromegaly alters the innate immune system independently of glucose metabolism.
๐ทFull post with takeaways on our LinkedIn page: linkedin.com/company/enea...
We spotlight a study that investigates how acromegaly alters the innate immune system independently of glucose metabolism.
๐ทFull post with takeaways on our LinkedIn page: linkedin.com/company/enea...
A new study suggests once-daily osilodrostat may enhance sleep & QoL via chronotherapy! ๐
๐ Full breakdown on our LinkedIn page:
www.linkedin.com/company/enea...
A new study suggests once-daily osilodrostat may enhance sleep & QoL via chronotherapy! ๐
๐ Full breakdown on our LinkedIn page:
www.linkedin.com/company/enea...
They discussed pituitary tumour management in pregnancy & advice for young neuroendocrinologists ๐ฉโโ๏ธ๐ง
Watch the full interview on LinkedIn and YouTube via EYRC: youtu.be/C8xxIGnydrk
They discussed pituitary tumour management in pregnancy & advice for young neuroendocrinologists ๐ฉโโ๏ธ๐ง
Watch the full interview on LinkedIn and YouTube via EYRC: youtu.be/C8xxIGnydrk
We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. ๐งช๐ง
Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. ๐งช๐ง
Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
Cabozantinib significantly prolongs PFS in patients with pancreatic & extrapancreatic NETs.
๐ Phase 3, placebo-controlled, multicenter study
๐ More insights on LinkedIn: www.linkedin.com/company/enea-young-researcher-committee
Cabozantinib significantly prolongs PFS in patients with pancreatic & extrapancreatic NETs.
๐ Phase 3, placebo-controlled, multicenter study
๐ More insights on LinkedIn: www.linkedin.com/company/enea-young-researcher-committee
A rare but serious condition often missed or misdiagnosed.
Early diagnosis can change lives.
#CushingsAwareness #RareDiseases #Endocrinology
A rare but serious condition often missed or misdiagnosed.
Early diagnosis can change lives.
#CushingsAwareness #RareDiseases #Endocrinology
Ravel et al. show additive effects of ALXN2420 (GH receptor antagonist) + octreotide on IGF1 suppression in vivo.
Exciting data for acromegaly treatment!
๐ More insights on LinkedIn:
www.linkedin.com/feed/update/...
Ravel et al. show additive effects of ALXN2420 (GH receptor antagonist) + octreotide on IGF1 suppression in vivo.
Exciting data for acromegaly treatment!
๐ More insights on LinkedIn:
www.linkedin.com/feed/update/...
@GP_R101 speaks with Dr. Federico Gatto about his journey from founding #EYRC to ENEA ExCo leadership & latest pituitary tumor research.
๐บ Watch now: youtu.be/5bMeohFpUVY
๐ More on LinkedIn: @enea-young-researcher-committee
@GP_R101 speaks with Dr. Federico Gatto about his journey from founding #EYRC to ENEA ExCo leadership & latest pituitary tumor research.
๐บ Watch now: youtu.be/5bMeohFpUVY
๐ More on LinkedIn: @enea-young-researcher-committee
We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3
๐First reported case of pit-gigantism linked to a germline MAX mutation
๐Myelolipoma as a new disease association in MEN5
๐Expansion of the phenotype beyond PPGLs
By @gp83.bsky.social
We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3
๐First reported case of pit-gigantism linked to a germline MAX mutation
๐Myelolipoma as a new disease association in MEN5
๐Expansion of the phenotype beyond PPGLs
By @gp83.bsky.social
The ENEA Young Researchers Committee (EYRC) is launching a brand-new podcast covering the latest expert interviews!
๐ง Listen now & subscribe:
๐ EYRC Podcast Hub: enea.org/category/eyr...
๐ Apple Podcasts: podcasts.apple.com/fr/podcast/e...
The ENEA Young Researchers Committee (EYRC) is launching a brand-new podcast covering the latest expert interviews!
๐ง Listen now & subscribe:
๐ EYRC Podcast Hub: enea.org/category/eyr...
๐ Apple Podcasts: podcasts.apple.com/fr/podcast/e...
โจ Our Mission:
๐น Strengthening ENEAโs visibility
๐น Representing early career researchers
๐น Organizing symposia & workshops
๐น And much more ...
โจ Our Mission:
๐น Strengthening ENEAโs visibility
๐น Representing early career researchers
๐น Organizing symposia & workshops
๐น And much more ...